Isoform | Protein Position | Transcript Position | Chromosomal Position (HG38) | Chromosomal Position (HG19) |
---|---|---|---|---|
IC | 29293 | 88102;88103;88104 | chr2:178557385;178557384;178557383 | chr2:179422112;179422111;179422110 |
N2AB | 27652 | 83179;83180;83181 | chr2:178557385;178557384;178557383 | chr2:179422112;179422111;179422110 |
N2A | 26725 | 80398;80399;80400 | chr2:178557385;178557384;178557383 | chr2:179422112;179422111;179422110 |
N2B | 20228 | 60907;60908;60909 | chr2:178557385;178557384;178557383 | chr2:179422112;179422111;179422110 |
Novex-1 | 20353 | 61282;61283;61284 | chr2:178557385;178557384;178557383 | chr2:179422112;179422111;179422110 |
Novex-2 | 20420 | 61483;61484;61485 | chr2:178557385;178557384;178557383 | chr2:179422112;179422111;179422110 |
Novex-3 | None | None | chr2:None | chr2:None |
SNV | RS | DUET |
PolyPhen-2 |
Condel |
Rhapsody |
REVEL |
MVP |
Source |
MAF |
Disease |
Zygosity |
Site annotation |
mCSM PPI |
Predicted PPI site |
Comments |
AFR |
AMR |
AMS |
ASJ |
EAS |
EUR |
FIN |
MDE |
NFE |
SAS |
OTH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R/C | rs191482653 | -0.197 | 1.0 | N | 0.797 | 0.464 | None | gnomAD-2.1.1 | 1.92691E-03 | None | None | None | None | I | None | 0 | 0 | None | 0 | 2.60379E-02 | None | 1.63388E-04 | None | 0 | 1.63983E-04 | 8.41515E-04 |
R/C | rs191482653 | -0.197 | 1.0 | N | 0.797 | 0.464 | None | gnomAD-3.1.2 | 7.49389E-04 | None | None | None | None | I | None | 2.41E-05 | 6.55E-05 | 0 | 0 | 2.04633E-02 | None | 9.43E-05 | 0 | 4.41E-05 | 2.06868E-04 | 4.78469E-04 |
R/C | rs191482653 | -0.197 | 1.0 | N | 0.797 | 0.464 | None | 1000 genomes | 3.19489E-03 | None | None | None | None | I | None | 0 | 0 | None | None | 1.59E-02 | 0 | None | None | None | 0 | None |
R/C | rs191482653 | -0.197 | 1.0 | N | 0.797 | 0.464 | None | Sasaki (2020) | None | Other | comp het with A9980T, A19938T | None | None | I | Genetic analysis of 2 siblings with asymmetric facial and limb weakness; variant prioritisation; no validation | None | None | None | None | None | None | None | None | None | None | None |
R/C | rs191482653 | -0.197 | 1.0 | N | 0.797 | 0.464 | None | gnomAD-4.0.0 | 6.71047E-04 | None | None | None | None | I | None | 2.66546E-05 | 1.66644E-05 | None | 0 | 1.87703E-02 | None | 3.1249E-05 | 3.30033E-04 | 8.89942E-05 | 2.08589E-04 | 1.76051E-03 |
R/H | rs202001776 | -0.539 | 1.0 | N | 0.778 | 0.376 | None | gnomAD-2.1.1 | 7.14E-05 | None | None | None | None | I | None | 4.95991E-04 | 5.65E-05 | None | 0 | 0 | None | 9.8E-05 | None | 0 | 2.34E-05 | 0 |
R/H | rs202001776 | -0.539 | 1.0 | N | 0.778 | 0.376 | None | gnomAD-3.1.2 | 1.57752E-04 | None | None | None | None | I | None | 4.82532E-04 | 1.30976E-04 | 0 | 0 | 0 | None | 0 | 0 | 1.47E-05 | 2.07211E-04 | 0 |
R/H | rs202001776 | -0.539 | 1.0 | N | 0.778 | 0.376 | None | gnomAD-4.0.0 | 3.90384E-05 | None | None | None | None | I | None | 3.60356E-04 | 6.66733E-05 | None | 0 | 0 | None | 0 | 0 | 1.52562E-05 | 1.20768E-04 | 4.80277E-05 |
SAV |
AlphaMissense (IC) |
AlphaMissense Class (IC) |
AlphaMissense (N2AB) |
AlphaMissense Class (N2AB) |
mCSM |
mCSM class |
PolyPhen-2 |
PolyPhen-2 Class |
Rhapsody |
Rhapsody Class |
Condel |
Condel Score |
Site annotation |
mCSM PPI |
Predicted PPI site |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R/A | 0.4796 | ambiguous | 0.4598 | ambiguous | 0.011 | Stabilizing | 0.999 | D | 0.645 | neutral | None | None | None | None | I |
R/C | 0.1887 | likely_benign | 0.2135 | benign | -0.272 | Destabilizing | 1.0 | D | 0.797 | deleterious | N | 0.478969789 | None | None | I |
R/D | 0.69 | likely_pathogenic | 0.6654 | pathogenic | -0.171 | Destabilizing | 1.0 | D | 0.747 | deleterious | None | None | None | None | I |
R/E | 0.4904 | ambiguous | 0.4502 | ambiguous | -0.114 | Destabilizing | 0.999 | D | 0.689 | prob.neutral | None | None | None | None | I |
R/F | 0.7113 | likely_pathogenic | 0.7084 | pathogenic | -0.229 | Destabilizing | 1.0 | D | 0.761 | deleterious | None | None | None | None | I |
R/G | 0.2586 | likely_benign | 0.2733 | benign | -0.164 | Destabilizing | 1.0 | D | 0.634 | neutral | N | 0.499490396 | None | None | I |
R/H | 0.1109 | likely_benign | 0.1177 | benign | -0.581 | Destabilizing | 1.0 | D | 0.778 | deleterious | N | 0.491028416 | None | None | I |
R/I | 0.5563 | ambiguous | 0.5187 | ambiguous | 0.433 | Stabilizing | 1.0 | D | 0.769 | deleterious | None | None | None | None | I |
R/K | 0.1216 | likely_benign | 0.1279 | benign | -0.154 | Destabilizing | 0.998 | D | 0.572 | neutral | None | None | None | None | I |
R/L | 0.3768 | ambiguous | 0.3746 | ambiguous | 0.433 | Stabilizing | 1.0 | D | 0.634 | neutral | N | 0.497626314 | None | None | I |
R/M | 0.4761 | ambiguous | 0.4515 | ambiguous | -0.038 | Destabilizing | 1.0 | D | 0.765 | deleterious | None | None | None | None | I |
R/N | 0.5895 | likely_pathogenic | 0.5569 | ambiguous | -0.035 | Destabilizing | 1.0 | D | 0.756 | deleterious | None | None | None | None | I |
R/P | 0.3351 | likely_benign | 0.3357 | benign | 0.312 | Stabilizing | 1.0 | D | 0.742 | deleterious | N | 0.428246373 | None | None | I |
R/Q | 0.1128 | likely_benign | 0.1176 | benign | -0.094 | Destabilizing | 1.0 | D | 0.748 | deleterious | None | None | None | None | I |
R/S | 0.5054 | ambiguous | 0.4899 | ambiguous | -0.313 | Destabilizing | 1.0 | D | 0.702 | prob.neutral | N | 0.445215981 | None | None | I |
R/T | 0.3387 | likely_benign | 0.3176 | benign | -0.132 | Destabilizing | 1.0 | D | 0.695 | prob.neutral | None | None | None | None | I |
R/V | 0.5739 | likely_pathogenic | 0.5534 | ambiguous | 0.312 | Stabilizing | 1.0 | D | 0.755 | deleterious | None | None | None | None | I |
R/W | 0.2536 | likely_benign | 0.2768 | benign | -0.329 | Destabilizing | 1.0 | D | 0.803 | deleterious | None | None | None | None | I |
R/Y | 0.4929 | ambiguous | 0.4926 | ambiguous | 0.077 | Stabilizing | 1.0 | D | 0.763 | deleterious | None | None | None | None | I |
Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.